Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS 2022-23 Annual Report Analysis
Wed, 2 Aug

J.B.CHEMICALS has announced its results for the year ended March 2023. Let us have a look at the detailed performance review of the company during FY22-23.

J.B.CHEMICALS Income Statement Analysis

  • Operating income during the year rose 29.9% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 28.2% YoY during the fiscal. Operating profit margins witnessed a fall and stood at 22.1% in FY23 as against 22.4% in FY22.
  • Depreciation charges increased by 57.5% and finance costs increased by 604.0% YoY, respectively.
  • Other income declined by 75.2% YoY.
  • Net profit for the year grew by 6.2% YoY.
  • Net profit margins during the year declined from 15.9% in FY22 to 13.0% in FY23.

J.B.CHEMICALS Income Statement 2022-23

No. of Mths Year Ending 12 Mar-22* 12 Mar-23* % Change
Net Sales Rs m 24,242 31,493 29.9%
Other income Rs m 401 99 -75.2%
Total Revenues Rs m 24,643 31,592 28.2%
Gross profit Rs m 5,426 6,958 28.2%
Depreciation Rs m 727 1,144 57.5%
Interest Rs m 51 361 604.0%
Profit before tax Rs m 5,049 5,552 10.0%
Tax Rs m 1,189 1,452 22.2%
Profit after tax Rs m 3,860 4,100 6.2%
Gross profit margin % 22.4 22.1
Effective tax rate % 23.5 26.2
Net profit margin % 15.9 13.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...

J.B.CHEMICALS Balance Sheet Analysis

  • The company's current liabilities during FY23 stood at Rs 6 billion as compared to Rs 5 billion in FY22, thereby witnessing an increase of 37.5%.
  • Long-term debt stood at Rs 4 billion as compared to Rs 0 million during FY22, a fall of 0.0%.
  • Current assets rose 21% and stood at Rs 16 billion, while fixed assets rose 43% and stood at Rs 25 billion in FY23.
  • Overall, the total assets and liabilities for FY23 stood at Rs 41 billion as against Rs 31 billion during FY22, thereby witnessing a growth of 34%.

J.B.CHEMICALS Balance Sheet as on March 2023

No. of Mths Year Ending 12 Mar-22* 12 Mar-23* % Change
Networth Rs m 20,715 23,587 13.9
 
Current Liabilities Rs m 4,552 6,257 37.5
Long-term Debt Rs m 0 3,832 0.0
Total Liabilities Rs m 30,691 40,981 33.5
 
Current assets Rs m 13,246 15,993 20.7
Fixed Assets Rs m 17,445 24,988 43.2
Total Assets Rs m 30,691 40,981 33.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



J.B.CHEMICALS Cash Flow Statement Analysis

  • J.B.CHEMICALS's cash flow from operating activities (CFO) during FY23 stood at Rs 6 billion, an improvement of 267.7% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY23 stood at Rs -10 billion on a YoY basis.
  • Cash flow from financial activities (CFF) during FY23 stood at Rs 4 billion, an improvement of 358% on a YoY basis.
  • Overall, net cash flows for the company during FY23 stood at Rs 204 million from the Rs 341 million net cash flows seen during FY22.

J.B.CHEMICALS Cash Flow Statement 2022-23

Particulars No. of months 12 12 % Change
Year Ending Mar-22 Mar-23
Cash Flow from Operating Activities Rs m 1,701 6,256 267.7%
Cash Flow from Investing Activities Rs m 23 -9,618 -
Cash Flow from Financing Activities Rs m -1,384 3,565 -
Net Cash Flow Rs m 341 204 -40.2%
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for J.B.CHEMICALS

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 53.0, an improvement from the EPS of Rs 50.0 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 2,554.5, stands at 48.2 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 8.4 times, while the price to sales ratio stands at 6.3 times.
  • The company's price to cash flow (P/CF) ratio stood at 25.7 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-22* 12 Mar-23*
Sales per share (Unadj.) Rs 313.7 407.0
TTM Earnings per share Rs 50.0 53.0
Diluted earnings per share Rs 49.9 53.0
Price to Cash Flow x 26.6 25.7
TTM P/E ratio x 31.6 48.2
Price / Book Value ratio x 6.0 5.7
Market Cap Rs m 123,307 134,983
Dividends per share (Unadj.) Rs 16.5 17.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for J.B.CHEMICALS

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 2.6x during FY23, from 2.9x during FY22. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 16.4x during FY23, from 99.6x during FY22. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 17.4% during FY23, from 18.6% during FY23. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 21.6% during FY23, from 24.6% during FY22. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 10.9% during FY23, from 12.7% during FY22. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-22* 12 Mar-23*
Current ratio x 2.9 2.6
Debtors’ Days Days 837 667
Interest coverage x 99.6 16.4
Debt to equity ratio x 0.0 0.2
Return on assets % 12.7 10.9
Return on equity % 18.6 17.4
Return on capital employed % 24.6 21.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how J.B.CHEMICALS has performed over the last 5 years, please visit here.

J.B.CHEMICALS Share Price Performance

Over the last one year, J.B.CHEMICALS share price has moved up from Rs 1,769.7 to Rs 2,554.5, registering a gain of Rs 784.9 or around 44.4%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 27,485.7 (down 0.6%). Over the last one year it has moved up from 22,962.3 to 27,485.7, a gain of 4,523 points (up 19.7%).

Overall, the S&P BSE SENSEX is up 13.2% over the year.

(To know more, check out historical annual results for J.B.CHEMICALS and quarterly results for J.B.CHEMICALS)

Annual Report FAQs

What is the current share price of J.B.CHEMICALS?

J.B.CHEMICALS currently trades at Rs 1,864.1 per share. You can check out the latest share price performance of J.B.CHEMICALS here...

What was the revenue of J.B.CHEMICALS in FY23? How does it compare to earlier years?

The revenues of J.B.CHEMICALS stood at Rs 31,592 m in FY23, which was up 28.2% compared to Rs 24,643 m reported in FY22.

J.B.CHEMICALS' revenue has grown from Rs 16,846 m in FY19 to Rs 31,592 m in FY23.

Over the past 5 years, the revenue of J.B.CHEMICALS has grown at a CAGR of 17.0%.

What was the net profit of J.B.CHEMICALS in FY23? How does it compare to earlier years?

The net profit of J.B.CHEMICALS stood at Rs 4,100 m in FY23, which was up 6.2% compared to Rs 3,860 m reported in FY22.

This compares to a net profit of Rs 4,485 m in FY21 and a net profit of Rs 2,724 m in FY20.

Over the past 5 years, J.B.CHEMICALS net profit has grown at a CAGR of 20.6%.

What does the cash flow statement of J.B.CHEMICALS reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of J.B.CHEMICALS reveals:

  • Cash flow from operations increased in FY23 and stood at Rs 6,256 m as compared to Rs 1,701 m in FY22.
  • Cash flow from investments decreased in FY23 and stood at Rs -9,618 m as compared to Rs 23 m in FY22.
  • Cash flow from financial activity increased in FY23 and stood at Rs 3,565 m as compared to Rs -1,384 m in FY22.

Here's the cash flow statement of J.B.CHEMICALS for the past 5 years.

(Rs m)FY19FY20FY21FY22FY23
From Operations1,9432,7573,1481,7016,256
From Investments-277239-2,30723-9,618
From Financial Activity-1,557-3,061-874-1,3843,565
Net Cashflow109-64-33341204

What does the Key Ratio analysis of J.B.CHEMICALS reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of J.B.CHEMICALS reveals:

  • Operating profit margins witnessed a fall and stood at 22.1% in FY23 as against 22.4% in FY22.
  • Net profit margins declined from 15.9% in FY22 to 13.0% in FY23.
  • Debt to Equity ratio for FY23 stood at 0.2 as compared to 0.0 in FY22.

Here's the ratio/financial analysis of J.B.CHEMICALS for the past 5 years.

 FY19FY20FY21FY22FY23
Operating Profit Margin (%)18.620.727.222.422.1
Net Profit Margin (%)11.815.322.015.913.0
Debt to Equity Ratio (x)0.00.00.00.00.2

 

Equitymaster requests your view! Post a comment on "J.B.CHEMICALS 2022-23 Annual Report Analysis". Click here!